Abstract
CYCLOSPORINA and FK506 inhibit T- and B-cell activation and other processes essential to an effective immune response1–3. In T lymphocytes these drugs disrupt an unknown step in the trans-mission of signals from the T-cell antigen receptor to cytokine genes that coordinate the immune response4–6. The putative intracellular receptors for FK506 and cyclosporin arecis-trans prolyl isomerases7–11. Binding of the drug inhibits isomerase activity8,10,11, but studies with other prolyl isomerase inhibitors12 and analysis of cyclosporin-resistant mutants in yeast suggest that the effects of the drug result from the formation of an inhibitory complex between the drug and isomerase13,14, and not from inhibi-tion of isomerase activity. A transcription factor, NF-AT, which is essential for early T-cell gene activation, seems to be a specific target of cyclosporin A and FK506 action because transcription directed by this protein is blocked in T cells treated with these drugs, with little or no effect on other transcription factors such as AP-1 and NF-κB (refs 15–17). Here we demonstrate that NF-AT is formed when a signal from the antigen receptor induces a pre-existing cytoplasmic subunit to translocate to the nucleus and combine with a newly synthesized nuclear subunit of NF-AT. FK506 and cyclosporin A block translocation of the cytoplasmic component without affecting synthesis of the nuclear subunit.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Borel, J. F., Feurer, C., Gubler, H. U. & Stahelin, H. Agents Actions 6, 468 (1976).
Sung, S. S. et al. J. exp. Med. 168, 1539–1551 (1988).
Gao, E.-K., Lo, D., Cheney, R., Kanagawa, O. & Sprent, J. Nature 336, 176–179 (1988).
Crabtree, G. R. Science 243, 355–361 (1989).
Schreiber, S. L. Science 251, 283–287 (1991).
Hohman, R. J. & Hultsch, T. New Biol. 2, 663–672 (1990).
Fischer, G. & Bang, H. Biochim. biophys. Acta 828, 39–42 (1985).
Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T. & Schmid, F. X. Nature 337, 476–478 (1989).
Handschumacher, R. E., Harding, M. W., Rice, J. & Drugge, R. J. Science 226, 544–547 (1984).
Lang, K. & Schmid, F. X. Nature 331, 453–455 (1988).
Standaert, R. F., Galat, A., Verdine, G. L. & Schreiber, S. L. Nature 346, 671–674 (1990).
Bierer, B. E., Somers, P. K., Wandless, T. J., Burakoff, S. J. & Schreiber, S. L. Science 250, 556–559 (1990).
Bierer, B. E. et al. Proc. natn. Acad. Sci. U.S.A. 87, 9231–9235 (1990).
Tropschug, M., Barthelmess, I. B. & Neupert, W. Nature 342, 953–955 (1989).
Shaw, J.-P. et al. Science 241, 202–205 (1988).
Emmel, E. A. et al. Science 246, 1617–1620 (1989).
Mattila, P. S. et al. EMBO J. 9, 4425–4433 (1990).
Wiskocil, R., Weiss, A., Imboden, J., Kamin-Lewis, R. & Stobo, J. J. Immun. 134, 1599–1603 (1985).
Fiering, S. et al. Genes Dev. 4, 1823–1834 (1990).
Rosen, M. K., Standaert, R. F., Galat, A., Nakatsuka, M. & Schreiber, S. L. Science 248, 863–866 (1990).
Dumont, F. J., Staruch, M. J., Koprak, S. L., Melino, M. R. & Signal, N. H. J. Immun. 144, 251–258 (1990).
Dumont, F. J. et al. J. Immun. 144, 1418–1424 (1990).
Karttunen, J. & Shastri, N. Proc. natn. Acad. Sci. U.S.A. 88, 3972–3976 (1991).
Kay, J. E., Doe, S. E. A. & Benzie, C. R. Cell. Immun. 124, 175–181 (1989).
Cirillo, R. et al. J. Immun. 144, 3891–3897 (1990).
Gunter, K. C., Irving, S. G., Zipfel, P. F., Siebenlist, U. & Kelly, K. J. Immun. 142, 3286–3291 (1989).
Kolestsky, A. J., Harding, M. W. & Handschumacher, R. E. J. Immun. 137, 1054–1059 (1986).
Kincaid, R. L., Takayama, H., Billingsley, M. L. & Sitkovsky, M. V. Nature 330, 176–178 (1987).
Tropschug, M., Wachter, E., Mayer, S., Schonbrunner, E. R. & Schmid, F. X. Nature 346, 674–677 (1990).
Sieklerka, J. J., Hung, S. H. Y., Poe, M., Lin, C. S. & Sigal, N. H. Nature 341, 755–757 (1989).
Harding, W. M., Galat, A., Uehling, D. E. & Schreiber, S. L. Nature 341, 758–760 (1989).
Ohlsson, H. & Edlund, T. Cell 45, 35–44 (1986).
Fried, M. G. & Crothers, D. M. Nucleic Acids Res. 9, 6505–6526 (1981).
Garner, M. M. & Revzin, A. Nucleic Acids Res. 9, 3047–3059 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Flanagan, W., Corthésy, B., Bram, R. et al. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352, 803–807 (1991). https://doi.org/10.1038/352803a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/352803a0
This article is cited by
-
Humoral and cellular immune responses to COVID-19 mRNA vaccines in immunosuppressed liver transplant recipients
Communications Medicine (2024)
-
Application of ATAC-seq in tumor-specific T cell exhaustion
Cancer Gene Therapy (2023)
-
Cyclosporine A and IFNγ licencing enhances human mesenchymal stromal cell potency in a humanised mouse model of acute graft versus host disease
Stem Cell Research & Therapy (2021)
-
Tacrolimus Decreases Cognitive Function by Impairing Hippocampal Synaptic Balance: a Possible Role of Klotho
Molecular Neurobiology (2021)
-
NFAT2 overexpression suppresses the malignancy of hepatocellular carcinoma through inducing Egr2 expression
BMC Cancer (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.